Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes
Semaglutide and PAD: Unveiling a Vascular Protective Revolution The medical world is abuzz with the latest findings on semaglutide, particularly its potential to revolutionize the treatment of peripheral artery disease (PAD) in individuals with type 2 diabetes. Recent data from the STRIDE trial, presented at the American Diabetes Association (ADA) Scientific Sessions, suggests the benefits … Read more